Clinical outcomes of ST elevation myocardial infarction patients without standard modifiable risk factors

Yu Suresvar Singh1, Hideki Wada1, Manabu Ogita1

  • 1Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka, Japan.

Journal of Cardiology
|December 3, 2023
PubMed

Insights

Patients with ST-segment elevation myocardial infarction (STEMI) who lacked standard modifiable cardiovascular risk factors (SMuRFs) had higher long-term mortality. This suggests individuals without traditional risk factors still face poor prognosis post-STEMI.

Area of Science:

  • Cardiology
  • Clinical Outcomes Research
  • Public Health

Background:

  • Standard modifiable cardiovascular risk factors (SMuRFs) include hypertension, diabetes, dyslipidemia, and smoking.
  • These factors are established risks for coronary artery disease.
  • The prognosis for ST-segment elevation myocardial infarction (STEMI) patients lacking SMuRFs is not well understood.

Purpose of the Study:

  • To investigate the association between the absence of SMuRFs and long-term clinical outcomes in STEMI patients.
  • To compare mortality rates in STEMI patients with and without SMuRFs.

Main Methods:

  • Retrospective analysis of consecutive STEMI patients undergoing primary percutaneous coronary intervention (PCI) from 1999-2015.
  • Primary endpoint: up to 5-year all-cause mortality.
  • Comparison of clinical characteristics and outcomes between patients with and without SMuRFs.

Main Results:

  • 6.4% of 1963 STEMI patients had no SMuRFs; they were older, leaner, and more often female.
  • Patients without SMuRFs exhibited significantly higher cumulative mortality over 5 years (log-rank p < 0.0001).
  • Absence of SMuRFs was independently associated with increased mortality risk (HR 1.59, 95% CI 1.14-2.21, p=0.006).

Conclusions:

  • STEMI patients without any SMuRFs undergoing primary PCI experienced higher mortality compared to those with at least one SMuRF.
  • Individuals without traditional cardiovascular risk factors have a poorer prognosis after STEMI and warrant increased clinical attention.
Abstract